News | Digital Radiography (DR) | July 06, 2017

Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017

Highlights will include new mini mobile DR system, digital breast tomosynthesis

Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017

July 6, 2017 — Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and mammography solutions at the American Healthcare Radiology Administrators (AHRA) 2017 Annual Meeting, July 9-12 in Anaheim, Calif. Fujifilm’s solutions are designed to optimize workflow and increase the safety and satisfaction of patients.

The company will be exhibiting the following solutions:

  • FDR AQRO: The FDR AQRO Mini Mobile System is a complete DR system that delivers high-resolution images and low patient dose in a variety of point-of-care and dedicated use settings, all within an ultra-lightweight mini mobile cart. The system combines Fujifilm’s core dose-saving technologies such as Irradiation Side Sampling (ISS) and noise reduction circuitry, with Virtual Grid and an all New Dynamic Visualization II image processing to produce exceptional images at gentle dose for all patient sizes and anatomy;
  • Aspire Cristalle: Fujifilm’s latest advancement in digital mammography includes digital breast tomosynthesis (DBT) and state-of-the-art dose saving, Hexagonal Close Pattern (HCP) image capture technology. The newest solution optimizes contrast, enables low dose and fast acquisition time, all while providing patient comfort with the company’s Comfort Paddle; and
  • FDR D-EVO GL:  The FDR D-EVO GL is the world's first and only, single-exposure long-length DR detector, according to Fujifilm. With easy patient positioning and rapid acquisition time, it simplifies exams for the technologist while lowering dose and discomfort for the patient. With a 17x49-inch field of view, it can accommodate all patient sizes and help prevent retakes, and when used with Fujifilm’s Virtual Grid, dose can be reduced as much as 50 percent compared to grid exams.

For all AHRA attendees, Fujifilm will host a complimentary breakfast symposium, “Optimizing Breast Cancer Detection, Departmental Efficiencies and the Patient Experience,” on Wednesday, July 12. This educational workshop hosted by Fujifilm Medical System U.S.A.’s Gregg Cretella, director of field sales support and David Wild, director of medical informatics, will explore the newest advances in digital mammography and medical informatics to understand how these tools can maximize financial, operational and clinical outcomes. Additionally, this session will help attendees evaluate the readiness of their current information technology (IT) infrastructure and make sound decisions when considering the purchase of new breast imaging technologies.

For more information: www.fujimed.com

Related Content

Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

News | Coronavirus (COVID-19) | June 26, 2020
June 26, 2020 — In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association wit
VolparaEnterprise data analysis shows mammography screening volumes are quickly increasing
News | Mammography | June 09, 2020
June 9, 2020 — More than 75 percent of hospitals and imaging centers that perform mammography across the United State
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...